IN SILICO ANALYSIS OF STRUCTURAL REQUIREMENTS FOR THIOPHENE DERIVATIVES AGAINST POLO LIKE KINASE-1 (PLK1)
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 6
Abstract
Objective: Development of anti-mitotic drugs for chemotherapy of cancer has been one of the main focuses of research in 21st century. Present work aims to study the structural requirements of thiophene derivatives against PLK1 as a target for designing novel strategies for cancer chemoprevention. To understand the structural requirements that will lead to enhanced inhibitory potencies, we have carried out 3D-QSAR (quantitative structure-activity relationship) studies on a series of thiophene derivatives as PLK1 receptor inhibitors.Methods: CoMFA, CoMSIA and molecular docking studies were performed on a series of thiophene derivatives as PLK1 receptor inhibitors using Sybyl 6.7.Results: We have successfully derived statistically significant model from 100 thiophene derivatives and validated, it against an external test set of 34 compounds and 66 molecules used in the training set. The CoMFA model yielded q2-0.845, r2-0.978. While the CoMSIA model yielded q2-0.804, r2-0.968. The predictive ability of these models supported by docking studies; produced better docking scores and binding affinity to the specified target polo like kinase1 (3THB) and moreover, the 3D QSAR model used for suggesting the next-generation lead analogues.Conclusion: 3D-QSAR has been established for a series of Polo like Kinase1 (PLK1) inhibitors employing the most widely used techniques CoMFA and CoMSIA. The conclusions derived from both models are similar and reliable. Docking studies are also performed to obtain the bioactive confirmations for the whole data-set. The obtained 3D contour maps along with the docking results provided a rational clue for the design of more favorable anti-mitotic agents. Overall, the structural modifications of the lead molecule have achieved to improve selective PLK1 inhibitory activity.Â
Authors and Affiliations
Shravan Kumar Gunda, Vijaya Lakshmi Lokirevu, Shyamasundara Chary Rudroju, Sri Swathi Mutya, Mahmood Shaik
Keywords
Related Articles
- EP ID EP578689
- DOI -
- Views 69
- Downloads 0
PHARMACOLOGICAL EVALUATION OF ANTI-INFLAMMATORY, ANALGESIC AND ANTIPYRETIC EFFECTS OF GYNOCARDIA ODORATA ROXB IN ANIMAL MODELS
Objective: The purpose of this investigation was to study the anti-inflammatory, analgesic, and antipyretic properties of methanol extract of Gynocardia odorata roxb (MEGO) in rats and mice.Methods: The plant material wa...
HEALTH RELATED QUALITY OF LIFE ASSESSMENT USING ST. GEORGE’S RESPIRATORY QUESTIONNAIRE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS ON COMBINED INHALED CORTICOSTEROIDS AND BRONCHODILATORS
Objective: Chronic diseases like COPD have significant effects on patient’s health-related quality of life (HRQoL). HRQoL measures additional indices as compared to objective measurements like spirometry. Our aim is to...
ANTIBACTERIAL ACTIVITY OF SELECTED MEDICINAL PLANT IN TRADITIONAL TREATMENT OF WOUND INFECTION IN SOUTHEAST INDIA
Objective: The wound healing potential of fruit peel of Pithecellobium dulce Benth, a plant traditionally used for wound treatment against wound- infecting bacteria, was assessed using disc diffusion and microtitre plate...
POTENTIAL DRUG-DRUG INTERACTIONS IN HEART FAILURE PATIENTS
Objective: The aim of the present study was to assess the prevalence, risk rating and the severity of hazardous pDDIs (potential drug-drug interactions) in the prescribed pharmacotherapy in the hospital discharged heart...
MODIFIED FORMULATION OF FEBUXOSTAT: IMPROVED EFFICACY AND SAFETY
Objective: Febuxostat, a xanthine oxidoreductase inhibitor, is a drug of choice for hyperuricemia and Gout. But it also suffers from drawbacks in terms of pharmacokinetic profile and toxicity. It is available as immediat...